Global  

NY Times: Eli Lilly Antibody Trial Paused Over Potential Safety Concern

Newsmax Tuesday, 13 October 2020
The clinical trial of Eli Lilly's COVID-19 antibody treatment has been paused because of a "potential safety concern," The New York Times reports.The Times said its report was based on emails that government officials sent Tuesday to researchers at testing sites, and was...
0
shares
ShareTweetSavePostSend
 
Video Credit: Reuters Studio - Published
News video: U.S. pauses Eli Lilly antibody drug trial over safety concern

U.S. pauses Eli Lilly antibody drug trial over safety concern 01:12

Eli Lilly and Co said on Tuesday that the government-sponsored clinical trial of its COVID-19 antibody treatment similar to one taken by U.S. President Donald Trump has been paused because of a safety concern. This report produced by Jillian Kitchener.

You Might Like


Related videos from verified sources

Jim Cramer Says Pause in Eli Lilly Trial Is 'Very Big Deal' [Video]

Jim Cramer Says Pause in Eli Lilly Trial Is 'Very Big Deal'

Jim Cramer said investors are underestimating the potential impact of a pause in the Eli Lilly coronavirus treatment trial.

Credit: The Street     Duration: 01:17Published
Eli Lilly pauses trial of antibody drug over safety concern [Video]

Eli Lilly pauses trial of antibody drug over safety concern

Eli Lilly and Co said on Tuesday that the government-sponsored clinical trial of its COVID-19 antibody treatment similar to one taken by U.S. President Donald Trump has been paused because of a safety..

Credit: Reuters Studio     Duration: 01:12Published
Citing Safety Reasons, Eli Lilly Halts COVID Treatment Trial [Video]

Citing Safety Reasons, Eli Lilly Halts COVID Treatment Trial

Drug maker Eli Lilly is hitting pause on a clinical trial for a coronavirus treatment; CBS2's Dick Brennan reports.

Credit: CBS 2 New York     Duration: 01:06Published

Related news from verified sources

Eli Lilly’s Antibody Trial Is Paused Over Potential Safety Concern

The drugmaker’s experimental antibody treatment is similar to the one President Trump received from Regeneron.
NYTimes.com

COVID-19 antibody treatment clinical trial paused over potential safety concern

Drugmaker Eli Lilly announced a temporary hold on its COVID-19 antibody therapy. The pause comes as a need for the treatment grows. A CDC report found that a...
CBS News

Coronavirus treatment trials halted over safety concerns

Eli Lilly has suspended tests on a coronavirus antibody treatment over a potential safety concern. This comes one day after Johnson & Johnson put its COVID-19...
CBS News